DU4475 Cells
USD 395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Información general
| Descripción | The DU4475 cell line is a human breast cancer cell line derived from a metastatic site. It is characterized by its aggressive nature and poor differentiation, often used in research to study the mechanisms of cancer metastasis and progression. The cell line has been utilized extensively to explore the therapeutic targets and the efficacy of anti-cancer drugs in treating highly invasive breast cancer types. Genetically, DU4475 exhibits a high level of genetic instability, which is a hallmark of many cancer cells. This feature makes it a valuable model for studying the genetic and molecular events leading to cancer development and progression. Research involving DU4475 often focuses on the pathways that regulate cancer cell growth, survival, and resistance to chemotherapy, making it a critical resource for oncological studies aiming to develop more effective cancer treatments. |
|---|---|
| Organismo | Human |
| Tejido | Breast |
| Enfermedad | Breast carcinoma |
| Lugar de metástasis | Skin |
| Aplicaciones | 3D cell culture, Immuno-oncology |
| Sinónimos | Du4475, DU-4475, Du-4475, DU 4475, Du 4475, Duke University 4475 |
Características
| Edad | 62 years |
|---|---|
| Género | Female |
| Origen étnico | European |
| Morfología | Epithelial |
| Propiedades de crecimiento | Clusters in Suspension |
Datos normativos
| Referencia | DU4475 (Cytion catalog number 300371) |
|---|---|
| Nivel de bioseguridad | 1 |
| NCBI_TaxID | 9606 |
| N.º de acceso de Cellosaurus | CVCL_1183 |
Datos biomoleculares
| Isoenzimas | AK-1, 1, ES-D, 1, G6PD, B, GLO-I, 2, Me-2, 2, PGM1, 1-2, PGM3, 1 |
|---|---|
| Tumorigénico | Yes, in nude mice |
| Virus | EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-1/2 -, MLV -, SMRV - |
| Cariotipo | Human flat-moded near-tetraploid karyotype with 12% polyploidy - 88-93<4n>xxxx, +1, +1, -5, -6, +9, -10, -10, +15, +15, -16, -16, +22, +4mar, i(1q)x2, ?add(1)(p35-36)x2, ?i(5p)x2, add(6)(p11), add(6)(p1?), del(6)(q25), add(9)(q35), del(11)(q24)x2, add(15)(p11)x2, add(17)(p1?)x2, del(21)(q22.2)x2 - sideline with -20, -20, +del(7)(p11) - gain of 1q and loss of 6q typical in breast carcinoma - resembles published karyotype |
Manejo
| Medio de cultivo | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suplementos | Supplement the medium with 15% heat-inactivated FBS |
| Subcultivo | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth. |
| Medio de congelación | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelación y cultivo de células |
|
| Atmósfera de incubación | 37°C, 5% CO2, humidified atmosphere. |
| Condiciones de envío | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condiciones de almacenamiento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Control de calidad y análisis molecular
| Esterilidad | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificado de análisis (CoA)
| Número de lote | Tipo de certificado | Fecha | Número de catálogo |
|---|---|---|---|
| 300371-221223 | Certificado de análisis | 23. May. 2025 | 300371 |
| 300371-020924 | Certificado de análisis | 18. Dec. 2025 | 300371 |